BridgeBio Pharma BBIO Total costs & expenses
Total costs & expenses at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by BridgeBio Pharma in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The official record: BridgeBio Pharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about BridgeBio Pharma's total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BridgeBio Pharma's total costs & expenses?
- BridgeBio Pharma (BBIO) reported total costs & expenses of $300.47M in Q1 2026.
- How has BridgeBio Pharma's total costs & expenses changed year-over-year?
- BridgeBio Pharma's total costs & expenses increased by 36.0% year-over-year, from $221.01M to $300.47M.
- What is the long-term trend for BridgeBio Pharma's total costs & expenses?
- Over 4 years (2021 to 2025), BridgeBio Pharma's total costs & expenses has grown at a 12.2% compound annual growth rate (CAGR), from $646.35M to $1.03B.
- What does total costs & expenses mean?
- The sum of all money spent by the company to operate its business during a specific period.
- How do you interpret total costs & expenses?
- An increase faster than revenue growth indicates margin compression, while a decrease relative to revenue suggests improved operational efficiency.
- How does total costs & expenses compare across companies?
- Standard metric for assessing the total financial burden of operations across all industries.